Quinuclidinone analogues as anticancer agents
US-2024217964-A1 · Jul 4, 2024 · US
US8969334B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-8969334-B2 |
| Application number | US-201414269154-A |
| Country | US |
| Kind code | B2 |
| Filing date | May 4, 2014 |
| Priority date | Sep 13, 2011 |
| Publication date | Mar 3, 2015 |
| Grant date | Mar 3, 2015 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
Compounds of Formula (I), their preparation and use in preventing or treating bacterial infections are disclosed.
Opening claim text (preview).
The invention claimed is: 1. A method for treating bacterial infection in a subject, said method comprising administering to said subject a pharmaceutically effective amount of a compound of Formula (I): or a stereoisomer or a pharmaceutically acceptable salt thereof; wherein M is a cation. 2. The method according to claim 1 , wherein M is hydrogen,…
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Human Necessities · mapped topic
Related publications grouped by family.
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Answers are generated from the same data shown on this page.